Edwards Lifesciences Corporation Accumulated Other Comprehensive Income
Edwards Lifesciences Corporation (EW) had Accumulated Other Comprehensive Income of -$214.60 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$214.60M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$221.30M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$238.30M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$250.40M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$214.60M 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$221.30M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$238.30M 10-Q · filed 2026-08-04 |
| 2025-09-30 | -$250.40M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$264.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | -$254.50M 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$244.50M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$252.50M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$220.20M 10-Q · filed 2024-07-31 |
| 2024-03-31 | -$233.30M 10-Q · filed 2024-04-29 |
| 2023-12-31 | -$242.80M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$250.10M 10-Q · filed 2023-10-27 |
| 2023-06-30 | -$255.50M 10-Q · filed 2023-07-28 |
| 2023-03-31 | -$255.40M 10-Q · filed 2023-04-28 |
| 2022-12-31 | -$254.90M 10-K · filed 2024-02-12 |
| 2022-09-30 | -$256.00M 10-Q · filed 2022-10-28 |
| 2022-06-30 | -$224.40M 10-Q · filed 2022-07-29 |
| 2022-03-31 | -$186.60M 10-Q · filed 2022-04-28 |
| 2021-12-31 | -$157.70M 10-K · filed 2023-02-13 |
| 2021-09-30 | -$155.40M 10-Q · filed 2021-10-29 |
| 2021-06-30 | -$159.60M 10-Q · filed 2021-07-30 |
| 2021-03-31 | -$172.40M 10-Q · filed 2021-04-28 |
| 2020-12-31 | -$161.10M 10-K · filed 2022-02-14 |
| 2020-09-30 | -$157.90M 10-Q · filed 2020-10-26 |
| 2020-06-30 | -$146.10M 10-Q · filed 2020-07-27 |
| 2020-03-31 | -$152.00M 10-Q · filed 2020-04-28 |
| 2019-12-31 | -$156.00M 10-K · filed 2021-02-12 |
| 2019-09-30 | -$155.80M 10-Q · filed 2019-10-25 |
| 2019-06-30 | -$138.20M 10-Q · filed 2019-07-26 |
| 2019-03-31 | -$141.20M 10-Q · filed 2019-04-26 |
| 2018-12-31 | -$138.50M 10-K · filed 2020-02-14 |
| 2018-09-30 | -$139.00M 10-Q · filed 2018-10-26 |
| 2018-06-30 | -$150.80M 10-Q · filed 2018-07-27 |
| 2018-03-31 | -$121.30M 10-Q · filed 2018-04-27 |
| 2017-12-31 | -$132.70M 10-K · filed 2019-02-15 |
| 2017-09-30 | -$142.70M 10-Q · filed 2017-10-27 |
| 2017-06-30 | -$157.80M 10-Q · filed 2017-07-28 |
| 2017-03-31 | -$181.50M 10-Q · filed 2017-04-28 |
| 2016-12-31 | -$198.40M 10-K · filed 2018-02-16 |
| 2016-09-30 | -$171.20M 10-Q · filed 2016-10-28 |
| 2016-06-30 | -$178.70M 10-Q · filed 2016-07-29 |
| 2016-03-31 | -$172.60M 10-Q · filed 2016-04-29 |
| 2015-12-31 | -$182.60M 10-K · filed 2017-02-17 |
| 2015-09-30 | -$169.20M 10-Q · filed 2015-10-29 |
| 2015-06-30 | -$146.60M 10-Q · filed 2015-07-29 |
| 2015-03-31 | -$147.90M 10-Q · filed 2015-04-29 |
| 2014-12-31 | -$100.90M 10-K · filed 2016-02-19 |
| 2014-09-30 | -$70.60M 10-Q · filed 2014-10-31 |
| 2014-06-30 | -$41.10M 10-Q · filed 2014-08-04 |
| 2014-03-31 | -$32.40M 10-Q · filed 2014-05-02 |
| 2013-12-31 | -$27.60M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$42.90M 10-Q · filed 2013-11-07 |
| 2013-06-30 | -$48.00M 10-Q · filed 2013-08-06 |
| 2013-03-31 | -$52.00M 10-Q · filed 2013-05-06 |
| 2012-12-31 | -$37.90M 10-K · filed 2016-02-19 |
| 2012-09-30 | -$37.10M 10-Q · filed 2012-11-07 |
| 2012-06-30 | -$51.00M 10-Q · filed 2012-08-07 |
| 2012-03-31 | -$24.60M 10-Q · filed 2012-05-09 |
| 2011-12-31 | -$37.50M 10-K · filed 2015-02-20 |
| 2011-09-30 | -$23.20M 10-Q · filed 2011-11-08 |
| 2011-06-30 | -$9.50M 10-Q · filed 2011-08-08 |
| 2011-03-31 | -$15.50M 10-Q · filed 2011-05-09 |
| 2010-12-31 | -$42.10M 10-K · filed 2014-02-28 |
| 2010-09-30 | -$24.20M 10-Q · filed 2010-11-08 |
| 2010-06-30 | -$53.00M 10-Q · filed 2010-08-06 |
| 2009-12-31 | -$7.90M 10-K · filed 2013-02-28 |
| 2008-12-31 | -$35.40M 10-K · filed 2012-02-27 |
| 2007-12-31 | $7.50M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |